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Abstract 
Background: The importance of the status of female health should have research priority due to the unique medi-
cal needs of women. Hence this paper attempts to explore the nexus of access to electricity, female education, and 
public health expenditure with female health outcomes in the SAARC-ASEAN countries.
Methods: Using the data of 2002–2018, and applying the cross-sectional dependence test, Modified Wald test, Wool-
dridge test, the Panel corrected standard error (PCSE) model, the Feasible generalized least square (FGLS) model, and 
the pair-wise Granger causality test, the robust outcomes on female health are found.
Results: Access to electricity, female education rate, public health expenditure, economic growth, and immunization 
rate, all have a positive effect on female life expectancy at birth, and a negative effect on the female adult mortality 
rate. The urbanization rate has a significantly positive impact on female life expectancy at birth but an insignificant 
impact on female adult mortality rate. The one-way causal relationship between the variables are also revealed.
Conclusions: All the results are rational and have important milestone for the health sector. The health status of 
females should be improved and protected by formulating effective policies on access to electricity, female educa-
tion, public health expenditure, immunization, economic growth, and urbanization.
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mortality
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Introduction
The importance of the status of female health cannot 
be overlooked and should be prioritized in order to bal-
ance gender equality and fulfil the unique medical needs 
of women. Female health status is often ignored, espe-
cially in developing countries, due to the disadvantaged 
conditions they face, created by discrimination which is 
deeply rooted in biological, socio-economic, cultural, 
political, and spiritual grounds [1, 2]. To end this under-
privileged situation, the United Nations Development 
Program (UNDP) focused on the sustainable develop-
ment goals to reduce gender inequality and ensure bet-
ter health facilities for females [3, 4]. Despite numerous 
efforts to ensure more facilities, the health care access 
of females still remains a greater challenge in the con-
temporary world. Thus further research for identifying 
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contributory factors to female health outcomes is quite 
appealing and crucial for policy makers.
Against this backdrop, our present study is an endeav-
our to probe the determining factors of female health 
in the selected 10 SAARC-ASEAN countries.1 Having 
a GDP of US$ 436.491 billion, these countries belong 
to the group of those having a total population of 2.007 
billion, out of whom 48.626% are female [5]. The aver-
age life expectancy of females in these countries in 2018 
was 73.985 years, where the highest life expectancy was 
in Thailand (80.704  years) and lowest was in Pakistan 
(68.109  years) [5]. These figures are lower than some 
other regions of the world such as EU and North Amer-
ica where average female life expectancy of these two 
regions are 83.867  years and 81.405  years, respectively 
[5]. In 2018, the average female adult mortality rate in 
these countries was 126.411 per 1,000 female adults (ages 
15–60 years), where the highest mortality is experienced 
by Bhutan (194.721 per 1000 female adults) and the low-
est mortality was in Sri Lanka (56.065 per 1000 female 
adults) [5]. This is higher than some other regions of the 
world such as EU and North America where the average 
female adult mortality of these two regions was 52.251 
and 81.935, respectively [5]. The average rate of access to 
electricity, female education, immunization, and urbani-
zation in these countries in 2018 were 90.611%, 90.500%, 
39.150%, respectively [5]. The average per capita public 
health expenditure in this region is US$119.279 [5]. All 
these indicators need more careful attention for ensuring 
better health outcomes of female.
Some empirical studies can be found in the literature 
[6–45, 61, 62, 72] that has endeavoured to uncover the 
determining elements of the health outcomes of people 
where inclusive health issues are rarely addressed. Female 
health outcomes have been analysed by some studies, but 
those studies failed to include some important factors 
like access to electricity, female education rate, immuni-
zation rate, economic growth rate, urbanization rate, and 
public health expenditure, all of which have important 
policy implications. Thus our main aim is to fill up the 
prevailing literary gaps in this current study, where we 
will thoroughly probe the effects of access to electricity, 
female education rate, public health expenditure, immu-
nization rate, economic growth rate, and urbanization 
rate on female health outcomes in the SAARC-ASEAN 
countries.
The rationale for selecting the variables is that: (i) 
access to electricity ensures better health outcomes for 
females by providing health related facilities, like get-
ting more health related knowledge from TV, Radio, etc. 
and become more health conscious, and receiving more 
medical benefits from electricity run appliances; (ii) 
female education creates awareness and provides proper 
guidelines about the healthy life to ensure better health 
for females; (iii) public health expenditure provides vari-
ous medical facilities at a lower cost for the improvement 
of female health. (iv) economic growth ensures better liv-
ing standards that facilitate improved female health; (v) 
a higher immunization rate generates protection against 
infectious diseases and safeguards female health; and (vi) 
urbanization creates different modern facilities that may 
positively affect female health. More rationalization of 
the selection of variables is provided in Sect. 3.1.
The major objectives of this study are:
 (i) To identify the impact of access to electricity, 
female education, public health expenditure eco-
nomic growth, immunization rate, and urbaniza-
tion on female health outcomes in the SAARC-
ASEAN countries.
 (ii) To detect the causality between access to electric-
ity, female education, public health expenditure, 
economic growth, immunization rate, urbaniza-
tion, and female health outcomes.
The main contributions of this study are: (i) this is the 
first study in the literature, to the best of our knowledge, 
that identifies the impact of access to electricity, female 
education, public health expenditure, economic growth, 
immunization rate, and urbanization on female health 
outcomes in the context of SAARC-ASEAN countries; 
(ii) this study utilizes the updated available and inclu-
sive data considering the period of 17 years (2002–2018); 
(iii) the outcomes are achieved by using robust econo-
metric tools: cross-sectional dependence test, Modified 
Wald test, Wooldridge test, the Panel corrected standard 
error (PCSE) model, the Feasible generalized least square 
(FGLS) model, and the pair-wise Granger causality test; 
and (vi) the results will provide unique guidelines for 
policy makers to advance the improved health status of 
females by considering access to electricity, female edu-
cation, public health expenditure, economic growth, 
immunization rate, and urbanization policies.
The study is aligned in the following order: follow-
ing the introduction, Sect.  2 reviews the past literature; 
Sect.  3 describes the methods; Sect.  4 presents s the 
results; Sect. 5 discusses the results; and Sect. 6 displays 
the conclusion and policy implications.
1 The SAARC-ASEAN countries are Bangladesh, Bhutan, India, Nepal, Paki-
stan, Sri Lanka, Brunei Darussalam, Myanmar, Philippines, and Thailand.
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Literature review
We will discuss the related literature concerning the 
linkages between our considered variables and health 
outcomes.
Access to electricity and female health outcomes nexus
Electricity is a vital element of modern society and has 
a significant impact on the availability and effectiveness 
of health facilities, as explained in existing literature [6, 
7, 11–14]. Wang [6] established that access to electric-
ity, as the mortality variable in urban areas, significantly 
reduces child mortality in 60 low-income countries. 
Adair-Rohani et al. [11] provided a specific example, and 
identified that electricity access plays significantly posi-
tive role on health in the case of 11 sub-Saharan African 
countries. Irwin et al. [12] pointed out that access to elec-
tricity has a positive influence on health outcomes, for 
example lower mortality, less susceptibility to diseases, 
and improved health care, whereas poor access to elec-
tricity increases those risks and leads to poorer quality 
health services. Chen et al. [7] found that rural electrifi-
cation programs improved primary health care facilities 
by increasing the utilization of health services, receiving 
vaccinations by children, and receiving maternal ante-
natal care because of the availability and functional-
ity of essential medical devices and health information 
is easily received through electronic media in case of 
Gujarat, India. In addition, Bridge et  al. [13] confirmed 
the positive but insignificant effect of access to electric-
ity on health in Nepal for the data period of 2010–2011. 
Hernández [14] observed that energy/electricity insecu-
rity led to adverse health consequences in the USA.
Female education rate and female health outcomes nexus
Because education increases consciousness about 
important health issues, it is also considered to be an 
important element for improving health outcomes. The 
significant role of education on health outcomes is shown 
by many contemporary researchers like [8, 15–22]. 
These researchers have focused on a range of disparate 
countries. Furnee et al. [15] explored the positive effects 
of education on the health status of both males and 
females in the US and Europe by using the meta-analysis 
approach. Similarly, Keats [19] found that female school-
ing had a positive impact on child health, using Uganda’s 
free primary education program of 1997 as a case study. 
McAlister and Baskett [16] surveyed 148 countries and 
observed that female education had the greatest effect 
on maternal mortality. Anlimachie and Avoada [17] 
cited the rural education program in Ghana, which had 
improved the social and health wellbeing of the citizens. 
Rahman and Alam [8] used the data of 1975–2019 and 
employed ARDL bounds test and pair-wise Granger 
causality analysis and ascertained that female education 
significantly reduced the child mortality rate in case of 
Bangladesh. Hurt et al. [18] established that females with 
at least minimum education had a lower mortality rate 
than those with no education in rural Bangladesh. Kan-
miki et  al. [20] identified that the children of mothers 
who had attained primary or junior high school educa-
tion were 45% less likely to experience under-five mortal-
ity than those whose mothers had no education in rural 
northern Ghana. Similar findings were also observed by 
Chowdhury et  al. [21] in the case of rural Bangladesh. 
Akinkugbe and Mohanoe [22] found that in Lesotho, 
female literacy had a significant determining effect on the 
life expectancy, infants and under-five mortality.
Public health expenditure and female health outcomes 
nexus
Public health expenditure has a significant role in 
improving health outcomes globally, as found in cur-
rent literature (see [9, 10, 23, 24, 26–31]). Novignon and 
Lawanson [10] ascertained that public health expendi-
ture had a positive and significant effect on child health 
in the case of 45 Sub-Saharan African countries during 
the period of 1995–2011. Nicholas et al. [23] found that 
the public health expenditure was inversely and signifi-
cantly related to infant and under-five mortalities, but 
had a negative and significant effect on maternal mortal-
ity in 40 sub-Saharan African countries during the period 
of 2000–2010. Farag et al. [26] outlined that government 
health spending had a significant effect in reducing infant 
and child mortality in case of 133 low and middle-income 
countries in the world. Similar results were also observed 
by Boachie and Ramu [27] for Ghana. Ahmad and Hasan 
[24] established that public health expenditure had a 
positive effect on health outcomes in Malaysia. Sango-
Coker and Bein [28] obtained that the female population 
lived longer than male and public health expenditure 
had positive impact on it in case of West African coun-
tries during the period of 1999–2014. Duba et  al. [29] 
found that there was a statistically significant association 
between life expectancies of both men and women and 
health care expenditures in the case of 210 countries dur-
ing 1995–2014. Rahman et  al. [9] found that the public 
health expenditure had a significant impact on reducing 
the death rate and infant mortality rate but an insignifi-
cant impact on life expectancy in case of SAARC-ASEAN 
regions. Akinkugbe and Mohanoe [22] showed that pub-
lic health expenditure had a significant effect on the life 
expectancy, infant and under-5 mortality in Lesotho. 
Similar identification was also revealed by Makochek-
anwa and Madziwa [30] for Zimbabwe, and Behera and 
Dash [72] for South-East Asia region. In contrast, Zaman 
et al. [31] found no significant relationship between total 
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health expenditure and increased life expectancy in 
Bangladesh.
Immunization rate and female health outcomes nexus
Immunization creates protection against various infec-
tious diseases and therefore ensures a healthier life for 
the people [22, 32–34, 61]. Pezzotti et al. [32] found that 
universal vaccination programs effectively reduced the 
preventive diseases of children in Italy where the data of 
1900–2015 were used. Applying a dynamic mathematical 
model of VZV transmission, Brisson et  al. [33] showed 
that the prevalence and morbidity of varicella decreased 
by the mass vaccination of 12-month-old children. Owais 
et  al. [34] found that immunization had a significant 
positive impact on child health in the case of Karachi, 
Pakistan in 2008 where the Poisson regression model 
was used. Rodrigues and Plotkin [61] identified that an 
increased immunization rate reduced the number of peo-
ple suffering from specific diseases and played a role in 
increasing life expectancy in the USA in 2017. Akinkugbe 
and Mohanoe [22] ascertained that the child immuniza-
tion rate has a significant effect on life expectancy, infant 
and under-5 mortality in Lesotho.
Economic growth and female health outcomes nexus
Economic growth ensures different health related 
advanced facilities and medical amenities that increase 
the health outcomes of people as observed in various 
works like [8, 9, 22, 25, 35–38]. Wang et al. [25] found 
that economic growth was positively linked with life 
expectancy in Pakistan by employing ARDL bounds 
test approach. Similar findings were also observed by 
Mahyar [35] for Iran, Ebenstein et  al. [37] for China, 
and Shahbaz et  al. [36] for 16 sub-Saharan African 
countries. Rahman et  al. [9] found that economic 
growth had a significant impact on increasing life 
expectancy and reducing the infant mortality rate but 
no significant impact on death rate in the case of 15 
SAARC-ASEAN countries that employed fixed effects, 
random effects and GMM models. Houweling et al. [65] 
identified that economic growth was associated with a 
reduction in under-5 mortality in the case of 43 devel-
oping countries. Rahman and Alam [8] also established 
that economic growth led to a significantly negative 
impact on the child mortality rate in Bangladesh. Wang 
[38] discerned the importance of economic develop-
ment for ensuring maternity care in 137 developing 
countries. Harttgen et al. [66] showed that an increase 
of economic growth reduced children’s underweight 
and under nutrition rate, both of which improved 
child health in sub-Saharan Africa. A similar finding 
was also revealed by Rashad and Sharaf [64] for Egypt. 
Gupta and Mitra [67] found that economic growth and 
health status were positively correlated and had a two‐
way relationship from the panel data of Indian states. 
On the other hand, Granados and Ionides [63] found 
that in the case of Sweden, the impact of economy on 
health was significant at lag 0 and 2 in the nineteenth 
and twentieth century, respectively but no evidence 
was explored for economic effects on mortality at larger 
lags. Similarly, Akinkugbe and Mohanoe [22] obtained 
no significant impact of economic growth on health 
outcomes in Lesotho.
Urbanization rate and female health outcomes nexus
Urbanization has a mixed effect on health status by 
ensuring different modern medical facilities as well as 
creating negative penalties for the public [8, 39–45, 62]. 
Wang [39] revealed that the urbanization was positively 
related to global health outcome by reducing mortality, 
under-five mortality, and infant mortality and increas-
ing life expectancy in 163 countries. Amouzou et  al. 
[40] found a negative association between urbanization 
and under-5 mortality in Sub-Saharan Africa. Panahi 
and Aleemran [41] also found the positive effect of 
urbanization on life expectancy in Middle Eastern and 
North African (MENA) Countries. Eckert and Kohler 
[43] also established a positive but insignificant asso-
ciation between urbanization and life expectancy in 
developing countries. In contrast, Antai and Moradi 
[44] found that under-5 mortality steadily increased 
as urbanization increased during 1983–2003 in Nige-
ria. Yang et  al. [45] found that most of the indicators 
of urbanization showed that it had a detrimental effect 
on female health outcomes in China. Adediran et  al. 
[42] found that urbanization significantly increased the 
frequency of metabolic syndrome (MetS) as an impor-
tant cause of morbidity and mortality in Nigeria. Torres 
et al. [62] ascertained that due to urban penalty urbani-
zation created high mortality and lower life expectancy 
in case of Scotland during the period of 1861–1910. 
Recently Rahman and Alam [8] also revealed a signifi-
cant positive association between urbanization and 
child mortality rate in Bangladesh.
From the critical investigation of the aforementioned 
literature it can be observed that the previous findings 
are not sufficiently convincing and encouraging to for-
mulate effective policies, particularly for female health. 
Moreover, unanimous, complete and comprehensive pol-
icy outcomes focusing exclusively on female health status 
are absent, especially in the SAARC-ASEAN countries. 
This is the main gap in the existing literature, and our 
current aim is to fill up this gap and provide uniform and 
inclusive policies to ensure better health for the female, 
which will be a milestone for the modern health sector.
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Methods
Theoretical or empirical rationale for choosing 
the variables
The theoretical justification for conducting this study is 
based on the different well-known and well-recognized 
theories and models, for example the human capital the-
ory by Becker [68], the health care model by Grossman 
[69], and the neoclassical model by Romer [70].
The rationale of choosing our studied variables is relies 
on the availability of data, from contemporary and pre-
vious literary works. We have considered the variables 
relating to life expectancy at birth, following Rahman 
et al. [9], Shahbaz et al. [36], Rodrigues and Plotkin [61], 
among others; mortality rate following Rahman et al. [9], 
Hurt et al. [18], Nicholas et al. [23], among others; access 
to electricity in line with Wang [6], Chen et al. [7], Bridge 
et al. [13], among others; female education rate following 
[8], Hurt et al. [18], Keats [19]; public health expenditure 
in line with Rahman et al. [9], Novignon and Lawanson 
[10], Nicholas et  al. [23], among others; immunization 
rate following Akinkugbe and Mohanoe [22], Owais et al. 
[34], Rodrigues and Plotkin [61], among others; urbani-
zation rate in line with Rahman and Alam [8], Wang 
[39], Amouzou et  al. [40], among others; and economic 
growth corresponding to the research undertaken by 
Rahman and Alam [8], Rahman et al. [9], Wang et al. [25], 
among others.
Variables and data
For this study the female health outcomes are consid-
ered as the dependent variables; for this, female life 
expectancy (FLE) at birth and female adult mortality rate 
(FAM) per 1,000 female adults (ages 15–60  years) are 
used as proxy variables. Along with these, the access to 
electricity (AEL), female education rate, immunization 
rate (IMM), urbanization rate (URB), gross domestic 
product (GDP) and public health expenditures (PUH) are 
taken as the independent variables. Access to electricity is 
the percentage of population having access to electricity; 
female education rate is the school enrolment of females 
at secondary level as a percentage of gross; immuniza-
tion rate is taken as measles vaccination taking rate as the 
percentage of children ages 12–23 months; GDP is used 
to see the reflection of economic growth; urbanization is 
defined as the urban population referring to people liv-
ing in urban areas as a percentage of total population; 
and the public health expenditure is taken as the domes-
tic general health expenditure per capita at current US$ 
funded by the government.
All the data are collected from the World Develop-
ment Indicator [5] of the World Bank over the years 
2002–2018. Some missing data of female school enrol-
ment at secondary level are linearly interpolated through 
E-views-11. To accomplish the estimation, we have used 
two well-known statistical software packages, STATA-16 
and E-views1.
The models used for the estimation of this study are 
presented below:
To get the direct elasticity of each variable from the 
coefficients, we have transformed all the variables of the 
Eqs. (1) and (2) into natural logarithmic form. Thus, the 
Eqs. (1) and (2) can be written as:
where, α is the intercept, and β1, β2, β3, β4, β5, β6 are coef-
ficients and εt is the error term.
Econometric approach
For empirical estimation we employed a number of 
renowned econometric approaches. We conducted the 
mentioned tests as: a cross-sectional dependence test 
to identify the shock effect; the Modified Wald test for 
group wise heteroskedasticity and Wooldridge test for 
aut-1ocorrelation in panel data to observe the heteroske-
dasticity and autocorrelation respectively. We employed 
the Panel corrected standard error (PCSE) model and the 
Feasible generalized least square (FGLS) model to obtain 
results that will show the robust relations between the 
variables; and the pair-wise Granger causality to deter-
mine the direction of causality.
Because of the resemblance of the geographic, eco-
nomic, historical, ethnic and political shocks, the cross-
sectional dependence of the variables may be observed. 
In this study we have employed four well-known cross-
sectional dependency tests: Breusch and Pagan [46] BP 
LM, Pesaran [47] scaled LM, Pesaran [47] CD, and Bal-
tagi et al. [48] biased-corrected scaled LM.
The Breusch and Pagan [46] model of examining the 
cross-sectional dependence among the panel data is:
(1)FLE = f (AEL, FED, PUH, GDP, IMM, URB)
(2)
FAM = f (AEL, FED, PUH, GDP, IMM, URB)
(3)
LNFLEt = + β1LNAELt + β2LNFEDt + β3LNPUHt
+ β4LNGDPt + β5LNIMMt + β6LNURBt + εt
(4)
LNFAMt = + β1LNAELt + β2LNFEDt + β3LNPUHt








Page 6 of 12Rahman and Alam  BMC Women’s Health          (2021) 21:383 
Pesaran [47] developed the LM statistics to address the 
limitations of the cure from the above model as:
If the cross-sectional size is greater than the time 
dimension, Pesaran [47] recommends the below test 
statistic:
Baltagi et al. [48] developed the simple asymptotic bias 
correction model, which is:
where   p̂ij  specifies a correlation among the errors. In 
this test, the null hypothesis is  H0: denotes no cross-sec-
tional dependence and the alternative hypothesis is  H1: 
prevalence of cross-sectional dependence.
To make an efficient and robust estimation of the fixed 
effect model, the model should be homoskedastic with 
no autocorrelation. If the model suffers from heteroske-
dasticity, the estimation may be consistent but inefficient 
[49]. To detect the heteroskedasticity the modified Wald 
test for group wise heteroskedasticity is performed [50, 
71]. Similarly, the presence of of autocorrelation is identi-
fied with the aid of Wooldridge [51] auto correlation test 
for panel data [52].
To overcome the complications of panel data estima-
tion arose due to cross-sectional dependence, heteroske-




































standard error (PCSE) and the feasible generalized least 
square (FGLS) models are considered to be best and most 
efficient. So, the difficulty created due to the panel nature 
of data, the PCSE, is the path finder [53]. Alternatively, 
the FGLS model is also able to overcome autocorrelation, 
heteroskedasticity, and cross-sectional dependence of the 
estimation [54]. Both the PCSE and FGLS methods are 
efficient and effective in addressing the heteroskedasticty, 
autocorrelation and outlier estimates [55–57, 73–76].
To observe the causality between the studied variables, 
pair-wise Granger [58] causality of stacked test (com-
mon coefficients) is employed, where three outcomes are 
revealed as one-way causality, two-way causality, and no 
causality. The pair-wise Granger causality equations for 
the panel data can be written as [59, 60].
where, t indicates the time period dimension of the panel, 
and i shows the cross-sectional dimension.
The stacked causality test considers all the coefficients 
are the same across all cross sections as common coef-
ficients [59, 60]. This can be portrayed as:
Hence the decision rule is H0: Y does not Granger 
causes X, and H1: Y Granger causes X.
(9)
Yi,t =A0,i + A1,iYi,t−1 +…⋯ + Ak ,iYi,t−1
+ B1,iXi,t−1 + Ωi,t
(10)
Xi,t =A0,i + A1,iXi,t−1 +…⋯ + Ak ,iXi,t−1
+ B1,iYi,t−1 + Ωi,t
(11)
A0,i = A0,j ,A1,i = A1,j , . . . . . . . . . .,Ak ,i = Ak ,j , ∀i, j
(12)
B0,i = B0,j ,B1,i = B1,j , . . . . . . . . . .,Bk ,i = Ak ,j , ∀i, j
Table 1 Descriptive statistics
All the variables are converted into the natural logarithm form
LNFLE LNFAM LNAEL LNFEDS LNPUH LNGDP LNIMM LNURB
Mean 4.267461 4.881569 4.309613 4.168679 3.008149 24.80490 4.455024 3.491938
Median 4.258905 4.962336 4.364889 4.250048 2.729451 25.07671 4.499810 3.505795
Maximum 4.390788 5.630968 4.605170 4.817100 6.691405 28.62914 4.595120 4.351941
Minimum 4.142976 4.026512 3.563369 3.201299 − 0.614827 20.07097 4.025352 2.656055
Std. Dev 0.067726 0.377061 0.266735 0.400890 1.726997 1.948057 0.148979 0.418792
Skewness 0.109554 − 0.471402 − 0.822261 − 0.611920 0.410460 − 0.341245 − 1.301273 0.130810
Kurtosis 1.805678 2.458394 2.802249 2.383728 2.608485 2.665012 3.954477 2.754632
Jarque–Bera 10.44376 8.374040 19.43354 13.29951 5.859286 4.094235 54.43028 0.911275
Probability 0.005397 0.015191 0.000060 0.001294 0.053416 0.129107 0.000000 0.634044
Sum 725.4684 829.8666 732.6342 708.6754 511.3853 4216.834 757.3542 593.6295
Sum Sq. Dev 0.775178 24.02752 12.02395 27.16040 504.0455 641.3423 3.750913 29.64029
Observations 170 170 170 170 170 170 170 170
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Results
Descriptive statistics
The results of the descriptive statistics are shown in 
Table 1. The mean, median, maximum, minimum, stand-
ard deviation, skewness, kurtosis, Jarque–Bera, probabil-
ity, sum, sum square deviation outcomes of our studied 
variables are presented, and denotes the robustness and 
consistency of the estimation.
Cross‑sectional dependence test results
The values of cross-sectional dependence tests and their 
probabilities are presented in Table  2. All the outcomes 
have confirmed the significance in all four tests. The coef-
ficients of the variables and their corresponding prob-
ability validated our rejection of the null hypothesis of 
cross-sectional independence. Therefore, Table  2 con-
firmed our use of cross-sectional dependence of the con-
sidered variables.
Heteroskedasticity and autocorrelation results
Table  3 displays the presence of heteroskedasticity and 
autocorrelation in the model. From the results of chi-
square and F-statistics along with their probability values 
we observe that there is existence of heteroskedastic-
ity and autocorrelation among the panel data of both 
female life expectancy at birth and female child mortality 
models.
The results of PCSE regression
After confirming cross-sectional dependence, heter-
oskedasticity and autocorrelation the (PCSE) model is 
estimated and the results of both models are reported in 
Table 4.
In case of female life expectancy at birth, from Table 4, 
it is observed that the coefficients of access to electric-
ity, female education, public health expenditure, GDP, 
immunization rate, and urbanization rate are 0.017, 
Table 2 Cross-sectional dependence test results
***Denotes significance at 1% level. Figures in the parentheses are probabilities
Variables Breusch–Pagan LM Pesaran scaled LM Bias‑corrected scaled LM Pesaran CD
LNFLE 748.844*** (0.000) 74.192*** (0.000) 73.879*** (0.000) 27.362*** (0.000)
LNFAM 592.784*** (0.000) 57.741*** (0.000) 57.429*** (0.000) 22.898*** (0.000)
LNAEL 433.194*** (0.000) 40.919*** (0.000) 40.607*** (0.000) 18.470*** (0.000)
LNFED 510.302*** (0.000) 49.047*** (0.000) 48.735*** (0.000) 21.893*** (0.000)
LNPUH 630.025*** (0.000) 61.667*** (0.000) 61.355*** (0.000) 24.956*** (0.000)
LNGDP 680.909*** (0.000) 67.031*** (0.000) 66.718*** (0.000) 25.981*** (0.000)
LNIMM 209.667*** (0.000) 17.357*** (0.000) 17.045*** (0.000) 5.621*** (0.000)
LNURB 530.505*** (0.000) 51.177*** (0.000) 50.864*** (0.000) 20.728*** (0.000)
Table 3 The results of heteroscedasticity and autocorrelation Test
Model LNFLE LNFAM Existence
Test Test statistic p value Test statistic p value
Modified Wald test for group 
wise heteroskedasticity
χ2 = 72.22 0.000 χ2 = 2128.93 0.000 Yes
Wooldridge test for autocor-
relation in panel data
F-statistic = 351.239 0.000 F-statistic = 14.621 0.004 Yes
Table 4 Panel corrected standard error (PCSE) model results
*** and ** denote significance at 1% and 5% levels respectively. Figures in the 
parentheses are z-statistics
Variables PCSE regression 
(LNFLE case)
PCSE regression (LNFAM case)
LNAEL 0.017*** (3.65) − 0.097** (− 2.04)
LNFED 0.041*** (6.96) − 0.211*** (− 4.01)
LNPUH 0.007*** (4.92) − 0.054*** (− 3.63)
LNGDP 0.009*** (5.04) − 0.039** (− 2.42)
LNIMM 0.028*** (4.85) − 0.117** (− 2.01)
LNURB 0.041*** (3.02) 0.108 (0.98)
_Constant 3.519*** (65.84) 7.478*** (17.75)
R-squared 0.9996 0.9843
Wald  chi2 446.94 105.66
Probability 0.000 0.000
N 170 170
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0.041, 0.007, 0.009, 0.028, and 0.041, respectively, which 
all are positive and are statistically significant at 1% 
level, except the urbanization rate. These imply that 1% 
increase of access to electricity, female education rate, 
public health expenditure, GDP, immunization rate, and 
urbanization rate will increase female life expectancy at 
birth by 0.017%, 0.041%, 0.007%, 0.009%, 0.028%, and 
0.041%, respectively.
These findings show that the access to electricity, 
female education rate, public health expenditure, GDP, 
immunization rate, and urbanization rate improves the 
female life expectancy at birth, which indicates their bet-
ter health status in the studied regions.
In Table 4, for the female adult mortality rate, the coef-
ficients of access to electricity, GDP, and immunization 
rate are −  0.097, −  0.039, and −  0.117, which all are 
negative and statistically significant at 5% level. The coef-
ficients of female education, and public health expendi-
ture, −  0.211, and −  0.054, consecutively, which are 
negative and are statistically significant at 1% level. These 
results imply that 1% increase of access to electricity, 
female education rate, public health expenditure, GDP, 
and immunization rate decrease the female adult mortal-
ity rate by 0.097%, 0.211%, 0.054%, 0.039%, and 0.117%, 
respectively. The coefficient of urbanization is 0.108 
which is positive but statistically insignificant. From the 
results, it is found that, access to electricity, female edu-
cation rate, public health expenditure, GDP, and immuni-
zation rate reduce the female adult mortality rate, which 
is desirable for explaining better female health status in 
the considered regions.
Robustness check: the results of FGLS regression
The robustness of the results obtained from the PCSE 
model is confirmed by the FGLS model as shown in 
Table  5. The Table  5 confirms that access to electricity, 
female education rate, public health expenditure, GDP, 
immunization rate, and urbanization rate positively and 
significantly affect female life expectancy. On the other 
hand, access to electricity, female education rate, pub-
lic health expenditure, GDP, and immunization rate 
have a negative effect on the female adult mortality rate, 
whereas the urbanization rate has an insignificant impact 
on the female adult mortality rate.
Pairwise granger causality tests results
The result of pair-wise Granger causality test is depicted 
in Table 6, where the results are presented by F-statistic 
and corresponding probability. We achieve one-way cau-
sality of female life expectancy with access to electric-
ity, female education rate, GDP, immunization rate, and 
urbanization rate. Similarly, we also obtained one-way 
causality of the female adult mortality rate with access to 
electricity, female education rate, and immunization rate.
Discussion
The outcomes of Tables 5 and 6 display the key determin-
ing factors of female life expectancy at birth and female 
adult mortality rate. We have found that access to electric-
ity positively affects female life expectancy and negatively 
affects the female adult mortality rate due to the conveni-
ence of the operation of modern medical instruments and 
preservation of valuable medicines, drugs, and vaccina-
tion and receiving health related information from pub-
lic media. Thus, more access to electricity enhances life 
extending facilities enough to reduce mortality rate and 
increase the life expectancy of female. These outcomes 
are in the line with the findings of Wang [6], Chen et al. 
[7], Adair-Rohani et al. [11], Irwin et al. [12], and Hernán-
dez [14]. A higher female education rate increases life 
expectancy and decreases the female adult mortality rate 
because education creates and enhances awareness and 
consciousness among females to consume nutritious food, 
to maintain a healthy life for them and for their children. 
Moreover, the educated female can acquire better health 
related information to stay healthy and lead a safe life. This 
result is consistent with those of Rahman and Alam [8], 
McAlister and Baskett [16], Keats [19], and Kanmiki et al. 
[20]. Public health expenditure has significant and posi-
tive effect on female life expectancy, and negative impact 
on the female adult mortality rate, as it promotes differ-
ent public hospitals, free of cost medicines, and lower cost 
medical facilities for people. Additionally, the more public 
health expenditure arranges better medical facilities (e.g. 
more hospitals, healthcare workers, medicines, etc.) for 
the poor and vulnerable portion of population including 
female. This outcome is similar to the findings of Rahman 
et  al. [9], Novignon and Lawanson [10], Nicholas et  al. 
Table 5 Feasible generalized least square (FGLS) model results
*** and ** denote significance at 1% and 5% levels respectively. Figures in the 
parentheses are z-statistics
Variables FGLS regression 
(LNFLE case)
FGLS regression (LNFAM case)
LNAEL 0.010*** (2.82) − 0.089** (− 2.41)
LNFED 0.024*** (5.14) − 0.138*** (− 3.79)
LNPUH 0.004*** (3.31) − 0.023** (− 2.34)
LNGDP 0.010*** (6.68) − 0.060*** (− 5.04)
LNIMM 0.014*** (3.07) − 0.090** (− 2.15)
LNURB 0.126*** (9.06) 0.093 (1.27)
_Constant 3.334*** (70.12) 7.570*** (22.96)
Wald  chi2 634.86 124.60
Probability 0.000 0.000
N 170 170
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[23], Ahmad and Hasan [24], and Behera and Dash [72]. 
The immunization rate also improves female life expec-
tancy and reduces female adult mortality. Vaccination cre-
ates herd immunity against infectious diseases, as a result 
children and adults become less affected by various types 
of infectious diseases, signifying an improved health sta-
tus for females. Therefore, the availability of vaccination to 
the mass level including female can ensure better immu-
nity that lengthens female life expectancy and reduces 
mortality rate This outcome is consistent with the results 
obtained by Pezzotti et al. [32], Brisson et al. [33], Owais 
et  al. [34], and Rodrigues and Plotkin [61], considering 
health outcomes. The per capita GDP positively influences 
female life expectancy and negatively influences female 
adult mortality, because economic growth enables gov-
ernments to spend more in the health sector, and ensures 
more medical facilities and better living standards for 
people, which significantly improves their health status. 
The higher growth rate makes family affluent; household 
head can spend more for the better health of family mem-
bers including females. This finding is similar to those of 
Rahman and Alam [8], Rahman et al. [9], Wang et al. [25], 
Mahyar [35], and Shahbaz et al. [36]. The urbanization rate 
has a positive effect on female life expectancy but an insig-
nificant effect on the female adult mortality rate because 
of improved urban health facilities, access to informa-
tion, better living standards, better employment resources 
and higher incomes for all people. The urban people also 
become more health conscious due to the availability of 
more urban facilities. Furthermore, in urban areas, most 
of the females are employed and can afford better health 
facilities and better food that enhance their life expectancy. 
This result is consistent with the results of Wang [39], 
Amouzou et  al. [40] and Panahi and Aleemran [41], but 
not consistent with the results of Rahman and Alam [8], 
Adediran et al. [42], and Torres et al. [62].
Conclusion and policy implications
This paper has explored the nexus of access to electric-
ity, female education, and public health expenditure with 
female health outcomes in the SAARC-ASEAN coun-
tries. Using the data of 2002–2018, and applying the 
Table 6 Causality test results
***, ** and * denote significance level at 1%, 5%, and 10%, respectively
Null Hypothesis: F‑Stat Prob Decision
LNFLE case
 LNAEL does not cause LNFLE 0.010 0.991 LNFLE → LNAEL (one-way causality)
 LNFLE does not cause LNAEL 7.788*** 0.001
 LNFED does not cause LNFLE 0.162 0.850 LNFLE → LNFED (one-way causality)
 LNFLE does not cause LNFED 4.654** 0.011
 LNPUH does not cause LNFLE 0.775 0.463 No causality
 LNFLE does not cause LNPUH 0.199 0.819
 LNGDP does not cause LNFLE 2.512* 0.085 LNGDP → LNFLE (one-way causality)
 LNFLE does not cause LNGDP 1.529 0.220
 LNIMM does not cause LNFLE 0.610 0.545 LNFLE → LNIMM (one-way causality)
 LNFLE does not cause LNIMM 2.948* 0.056
 LNURB does not cause LNFLE 22.828*** 0.000 LNURB → LNFLE (one-way causality)
 LNFLE does not cause LNURB 1.769 0.174
LNFAM case
 LNAEL does not cause LNFAM 0.189 0.828 LNFAM → LNAEL (one-way causality)
 LNFAM does not cause LNAEL 5.038*** 0.008
 LNFED does not cause LNFAM 0.162 0.851 LNFAM → LNFED (one-way causality)
 LNFAM does not cause LNFED 2.356* 0.098
 LNPUH does not cause LNFAM 0.258 0.773 No causality
 LNFAM does not cause LNPUH 0.683 0.507
 LNGDP does not cause LNFAM 0.275 0.759 No causality
 LNFAM does not cause LNGDP 1.601 0.205
 LNIMM does not cause LNFAM 0.162 0.851 LNFAM → LNIMM (one-way causality)
 LNFAM does not cause LNIMM 3.826** 0.024
 LNURB does not cause LNFAM 1.925 0.150 No causality
 LNFAM does not cause LNURB 0.330 0.719
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cross-sectional dependence test, Modified Wald test, 
Wooldridge test, the PCSE model and the FGLS model, 
and the pair-wise Granger causality test, robust results 
have been obtained. Access to electricity, female educa-
tion rate, public health expenditure, economic growth, 
and immunization rate have a positive effect on female 
life expectancy at birth, and a negative effect on the 
female adult mortality rate. The urbanization rate has 
a significant positive impact on female life expectancy 
at birth but an insignificant impact on the female adult 
mortality rate. A one-way causal relationship between the 
variables is also noted. All the results are logical and gen-
erate important milestones for the health sector. These 
results may be said to apply, not only for the regions stud-
ied but globally.
The important policy implications of the study are: 
the health status of females should be improved and 
protected by formulating effective policies on access to 
electricity, female education, public health expenditure, 
immunization, economic growth, and urbanization. In 
this context the following specific recommendations 
should be prioritized:
 (i) Ensuring more access to electricity: More electric-
ity access plays role in increasing female life expec-
tancy and reducing female mortality rate in the 
studied region. Electricity facility also helps females 
to be health conscious via electricity run devices 
and media by and also helps to take proper medical 
treatment with modern electricity led medications. 
It also helps female to get employment and thus 
discourages child marriages. Use of electricity facil-
itates easy access to print and electronic media that 
increases female awareness, which plays an impor-
tant role in reducing early marriage related death 
and increasing life expectancy. For this reason, an 
effective and efficient policy formulation to ensure 
more electricity access should be formulated that 
will be conducive to female health.
 (ii) Spreading more female education: More education 
of female ensures more life expectancy and lower 
female mortality rate[19, 20]). Thus, all types of 
barriers of education for female should be eradi-
cated and priority should be given to a female 
friendly environment for spreading more female 
education, so that, among others, they will be more 
aware of about health issues. For this reason more 
female educational institutions, financial facili-
ties by offering various scholarships, and a better 
educational environment are required which urge 
dynamic policy efforts.
 (iii) Greater public health expenditure: Our findings of 
public health expenditure on female life expectancy 
and female mortality rate plausible. More public 
health expenditure offers more medical facilities 
at no cost or minimum costs As a result, people 
including female can easily enjoy required health 
facilities which reduces mortality and lengthens 
female life expectancy.. Therefore, the governments 
of these countries should increase budget alloca-
tion for public health with priority for females’ 
health as women has unique health issues [77]. In 
this regard, supplying more doctors specializing in 
female health, establishing more community clinics 
at the foundational level, more subsidies for medi-
cines, and providing modern and improved medi-
cal equipment are essential.
 (iv) Larger coverage on immunization: As immuniza-
tion builds herd immunity against different types 
of infectious diseases, a greater coverage of immu-
nization may help females to achieve better health 
outcomes [32, 33]. Necessary arrangements should 
be made in such a way that all people including 
female may get vaccinated. In this case, secular, 
unbiased, and gender friendly immunization poli-
cies should be formulated.
 (v) Sustainable economic growth policy Our findings of 
economic growth on health outcomes are consist-
ent too because economic growth brings ameni-
ties and ensures modern types of different facili-
ties for better health, which increases female life 
expectancy and declines female mortality rate. A 
sustainable and effective economic growth policy 
can ensure modern health facilities for females. 
Therefore, effective, efficient, updated, and health-
focused economic growth policies should be pio-
neering across the regions for making sustainable 
future for ensuring better female health status.
 (vi) Planned urbanization As urbanization increases 
female life expectancy, the more panned urban 
facilities for female should also be ensured. Because 
unplanned urbanization may create detrimental 
consequences on human health through creating 
pollution, unhygienic water and sanitation facili-
ties, congestion, and various socio-cultural mal-
adjustments like slums [8, 62]. A proficient, green, 
and sustainable well-organized and well-planned 
urbanization policy should be undertaken to 
ensure better health status for all people, but par-
ticularly for females.
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